1 Min Read
Feb 9 (Reuters) - Ajanta Pharma Ltd
* Says company's Paithan facility was recently inspected by US FDA and company has issued one procedural related 483.
* Says company has issued one procedural related 483
* Says is in process of responding to same within stipulated time prescribed by US FDA. Source text - (bit.ly/2lt7NpZ) Further company coverage: